pharmathene inc (PIP:NYSE Amex)
John A. T. Young Ph.D.
Member of Scientific Advisory Board, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 44 board members in 2 different organizations across 1 different industries.|
See Board Relationships
John A. T. Young Ph.D. is a Professor at The Salk Institute of Biological studies in La Jolla, CA. Dr. Young served as Howard M. Temin professor in Cancer research at the McArdele Laboratory of Cancer Research University of Wisconsin. He served as Chairman of CMB Graduate program. He serves as Member of the Board of Directors of Salk Institute for Biological Studies. He also serves as a Member Of Scientific Advisory Board of Pharmathene, Inc.
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|M. Michelle Berrey M.D., MPH.||Chief Executive Officer, President, Chief Medical Officer and Director|
|Paul Chaplin MSc, Ph.D.||Chief Executive Officer and President|
Bavarian Nordic A/S
|Anthony S. Marucci M.B.A.||Founder, Chief Executive Officer, President and Director|
Celldex Therapeutics, Inc.
|Peter Mørch Eriksen BBA||Chief Executive Officer and Administration Director|
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|